L. Tubarão

Cellular and Molecular Immunology Approaches for the Development of Immunotherapies against the New Coronavirus (SARS-CoV-2): Challenges to Near-Future Breakthroughs

A. A. Ano Bom, S. Missailidis, J. Melgaço, 2020, Journal of immunology research.

Protective Immunity of COVID-19 Vaccination with ChAdOx1 nCoV-19 Following Previous SARS-CoV-2 Infection: A Humoral and Cellular Investigation

Renata Tourinho Santos, A. A. Ano Bom, N. S. Alves, 2022, Viruses.

Safety and immunogenicity of 17DD attenuated yellow fever vaccine in howler monkeys (Alouatta spp.)

Renata Tourinho Santos, A. A. Ano Bom, R. Marchevsky, 2020, Journal of medical primatology.

Early IFN-Gamma Production after YF 17D Vaccine Virus Immunization in Mice and Its Association with Adaptive Immune Responses

R. Galler, M. Bonaldo, L. Tubarão, 2013, PloS one.

Persistence of immunity against hepatitis A in Brazilian children vaccinated with a single dose of inactivated virus vaccine

F. Souto, M. A. Pinto, J. Melgaço, 2023, Journal of viral hepatitis.

CLEC5A expression can be triggered by spike glycoprotein and may be a potential target for COVID‐19 therapy

M. A. Pinto, L. Villar, J. Melgaço, 2022, Journal of medical virology.

Two-Step In Vitro Model to Evaluate the Cellular Immune Response to SARS-CoV-2

Carolina Q. Sacramento, A. A. Ano Bom, Y. Mendes, 2021, Cells.